ABSTRACT
Compared with all-small-molecule (ASM) and other types of organic solar cells (OSCs), the small molecule donor:polymer acceptor (SMD:PA) OSCs develop much slower due to the lack of material matching rules. Herein, by changing the end-cap substituent of the small molecule donor from ethyl (MPhS-C2) to benzyl (MPhS-Ph), the different selection rules of donor properties and thermal annealing (TA) treatment between the ASM and the SMD:PA system under tetrahydrofuran processing are thoroughly investigated. Therefore, MPhS-Ph exhibits more ordered molecular packing, leading to better adaptability in the SMD:PA system without TA; while the inferior molecular packing of MPhS-C2 after spin-coating performs better in the ASM system with TA. Whether spin-coating or TA process dominates morphological optimization also dominates their energy loss. Therefore, the MPhS-Ph:PYF-T-o and MPhS-C2:BTP-eC9 based devices achieve the highest power conversion efficiency (PCE) of 12.1% and 15.7%, respectively, both of which are cutting-edge PCEs in their own type of OSCs fabricated by non-halogen solvent. This result suggests that intrinsic strong crystallization independent of the thermal drive is hoped in SMD:PA-OSCs, while high miscibility after spin-coating and proper assembly under thermal drive is expected in ASM-OSCs, providing deep understanding and guidance in highly efficient materials design rules in both ASM-OSCs and SMD:PA-OSCs.
ABSTRACT
BACKGROUND: Studies have shown the existence of health concordance between patients with type 2 diabetes mellitus (T2DM) and their spouses, and also that spouses could influence the effect of self-management, benefiting patients' health. However, these studies are heterogeneous and the evidence is inconclusive. OBJECTIVE: To synthesize evidence from published randomized controlled trials: the interventional effects and the quality of study performance, also to identify the research gap and the directions for future studies. METHODS: We performed the scoping review by following the PRISMA-ScR guidance. We searched and examined the reports from MEDLINE, EMBASE, PsychInfo, CINAHL Plus by the pre-specified criteria. Key characteristics and information of eligible reports were extracted, analysed and synthesized comprehensively, and the results were presented in the form of words and diagrams. RESULTS: We identified 5 reports from 4 studies out of 3479 records included. Qualified studies indicated a positive effect of couple-based interventions on couples' distress. Insufficient evidence on physiological health or health behaviours was identified owing to the small number of included studies and inconsistent assessment outcomes. The methodological quality across these studies was generally low due to inadequate reporting of study process and substantial biases. CONCLUSIONS: Couple-based interventions for patients with T2DM showed small effects on the couple's distress while the effects of other outcomes were inconclusive. Future studies should strengthen methodologies by using standard measures of core diabetic outcomes, including detailed assessments of implementation process, and taking a dyadic approach to systematically examine the effects.
Subject(s)
Diabetes Mellitus, Type 2 , Self-Management , Aged , Diabetes Mellitus, Type 2/therapy , Humans , Middle Aged , SpousesABSTRACT
BACKGROUND: China's limited health care resources cannot meet the needs of chronic disease treatment and management of its rapid growing ageing population. The improvement and maintenance of patient's self-management is essential to disease management. Given disease management mainly occurs in the context of family, this study proposes to validate a Couple-based Collaborative Management Model of chronic diseases that integrates health professionals and family supporters; such as to empower the couples with disease management knowledge and skills, and to improve the couples' health and quality of life. METHODS: The proposed study will validate a couple-based collaborative management model of Type 2 Diabetes Mellitus (T2DM) in a community-based multicenter, two-arm, randomized controlled trial of block design in Guangzhou, China. Specifically, 194 T2DM patients aged ≥55 and their partners recruited from community health care centers will be randomized at the patient level for each center at a 1:1 ratio into the couple-based intervention arm and the individual-based control arm. For the intervention arm, both the patients and their spouses will receive four-weekly structured group education & training sessions and 2 months of weekly tailored behavior change boosters; while these interventions will be only provided to the patients in the control group. Behavior change incentives will be targeted at the couples or only at the patient respectively. Treatment effects on patients' hemoglobin, spouses' quality of life, alongside couples' behavior outcomes will be compared between arms. Study implementation will be evaluated considering its Reach, Effectiveness, Adoption, Implementation and Maintenance following the RE-AIM framework. DISCUSSION: This study will generate a model of effective collaboration between community health professionals and patients' family, which will shield light on chronic disease management strategy for the increasing ageing population. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR1900027137, Registered 1st Nov. 2019.
